ロード中...
Developing Outcomes Assessments as Endpoints for Registrational Clinical Trials of Antibacterial Drugs: 2015 Update From the Biomarkers Consortium of the Foundation for the National Institutes of Health
One important component in determining the benefits and harms of medical interventions is the use of well-defined and reliable outcome assessments as endpoints in clinical trials. Improving endpoints can better define patient benefits, allowing more accurate assessment of drug efficacy and more info...
保存先:
| 出版年: | Clin Infect Dis |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4741356/ https://ncbi.nlm.nih.gov/pubmed/26668337 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ927 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|